We confirm that that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Marco de Curtis decurtis@istituto-besta.it Astrid Nehlig Jeffrey Noebels Raman Sankar Annamaria Vezzani Unit of Epileptology and Experimental Neurophysiology and Neuroscience Laboratories, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy; INSERM U 666, Faculty of Medicine, Strasbourg, France; Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.; Division of Pediatric Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.; and Laboratory Experimental Neurology, Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy
[1]
M. Sahin,et al.
Febrile infection–related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome
,
2011,
Epilepsia.
[2]
F. Y. Ismail,et al.
AERRPS, DESC, NORSE, FIRES: Multi‐labeling or distinct epileptic entities?
,
2011,
Epilepsia.
[3]
U. Stephani,et al.
Febrile infection–related epilepsy syndrome (FIRES): A nonencephalitic encephalopathy in childhood
,
2010,
Epilepsia.
[4]
A. Cole,et al.
Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults—Infectious or not?
,
2009,
Journal of the Neurological Sciences.
[5]
D. Lowenstein,et al.
Refractory Status Epilepticus in Suspect Encephalitis
,
2008,
Neurocritical care.